Hakutulokset - Nixon, D F

Routine full blood counts as indicators of acute viral infections. Tekijä Nixon, D F, Parsons, A J, Eglin, R P

Hae kokoteksti Hae kokoteksti

Lymphocyte-mediated cytotoxicity against allogeneic tumour cells. IV. Fine specificity mapping and characterization of concanavalin A-activated cytotoxic effector lymphocytes. Tekijä Waterfield, J D, Nixon, D F, Mair, M G

Hae kokoteksti Hae kokoteksti

Cellular and humoral antigenic epitopes in HIV and SIV. Tekijä Nixon, D F, Broliden, K, Ogg, G, Broliden, P A

Hae kokoteksti Hae kokoteksti

Rational Peptide Selection To Detect Human Immunodeficiency Virus Type 1-Specific T-Cell Responses under Resource-Limited Conditions Tekijä Willberg, C. B., Pillai, S. K., Sharp, E. R., Rosenberg, M. G., Agudelo, J. D., Barbour, J. D., Nixon, D. F.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Potentially Exposed but Uninfected Individuals Produce Cytotoxic and Polyfunctional Human Immunodeficiency Virus Type 1-Specific CD8(+) T-Cell Responses Which Can Be Defined to the... Tekijä Erickson, A. L., Willberg, C. B., McMahan, V., Liu, A., Buchbinder, S. P., Grohskopf, L. A., Grant, R. M., Nixon, D. F.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Why do cytotoxic T lymphocytes fail to eliminate hepatitis C virus? Lessons from studies using major histocompatibility complex class I peptide tetramers. Tekijä Lechner, F, Sullivan, J, Spiegel, H, Nixon, D F, Ferrari, B, Davis, A, Borkowsky, B, Pollack, H, Barnes, E, Dusheiko, G, Klenerman, P

Hae kokoteksti Hae kokoteksti

Antiretroviral Drug Therapy Alters the Profile of Human Immunodeficiency Virus Type 1-Specific T-Cell Responses and Shifts the Immunodominant Cytotoxic T-Lymphocyte Response from G... Tekijä Karlsson, A. C., Chapman, J. M., Heiken, B. D., Hoh, R., Kallas, E. G., Martin, J. N., Hecht, F. M., Deeks, S. G., Nixon, D. F.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Direct Ex Vivo Measurement of CD8(+) T-Lymphocyte Responses to Human Parvovirus B19 Tekijä Tolfvenstam, T., Oxenius, A., Price, D. A., Shacklett, B. L., Spiegel, H. M. L., Hedman, K., Norbeck, O., Levi, M., Olsen, K., Kantzanou, M., Nixon, D. F., Broliden, K., Klenerman, P.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Decay Kinetics of Human Immunodeficiency Virus-Specific Effector Cytotoxic T Lymphocytes after Combination Antiretroviral Therapy Tekijä Ogg, G. S., Jin, X., Bonhoeffer, S., Moss, P., Nowak, M. A., Monard, S., Segal, J. P., Cao, Y., Rowland-Jones, S. L., Hurley, A., Markowitz, M., Ho, D. D., McMichael, A. J., Nixon, D. F.

Hae kokoteksti Hae kokoteksti

Skewed Distribution of Natural Killer Cells in Psoriasis Skin Lesions Tekijä Batista, M. D., Ho, E. L., Kuebler, P. J., Milush, J. M., Lanier, L. L., Kallas, E. G., York, V. A., Chang, D., Liao, W., Unemori, P., Leslie, K. S., Maurer, T., Nixon, D. F.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Antiviral gene expression in psoriasis Tekijä Raposo, R.A., Gupta, R., Abdel-Mohsen, M., Dimon, M., Debbaneh, M., Jiang, W., York, V.A., Leadabrand, K.S., Brown, G., Malakouti, M., Arron, S., Kuebler, P.J., Wu, J.J., Pillai, S.K., Nixon, D.F., Liao, W.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Lower numbers of circulating natural killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease Tekijä Ndhlovu, L C, Snyder-Cappione, J E, Carvalho, K I, Leal, F E, Loo, C P, bruno, F R, Jha, A R, Devita, D, Hasenkrug, A M, Barbosa, H M R, Segurado, A C, Nixon, D F, Murphy, E L, Kallas, E G

Hae kokoteksti Hae kokoteksti Hae kokoteksti